X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Pharma Contract Manufacturing 2025

Content Team by Content Team
7th December 2024
in Press Statements

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The pharma contract manufacturing industry is projected to grow substantially, reaching $320 billion by 2029. This growth is linked to rising drug development costs, rapid technological advancements, and evolving regulatory rules.

In the fast-paced world of pharmaceuticals, effective partnerships between CMOs and pharmaceutical companies are crucial for swiftly producing life-saving drugs. As the global CMO market continues to grow, it’s imperative for pharmaceutical companies to strategically select and collaborate with the right partners to optimise operations, minimise costs, and drive innovation.

Pharma Contract Manufacturing 2025 will provide a platform for sharing best practice, building relationships and addressing common challenges collectively. From partner selection and cost management to digital transformation and sustainability, we will explore practical solutions and real-world case studies to help you build and sustain successful partnerships in today’s uncertain environment. Join us in Berlin at the Mercure Hotel from the 26-27th March 2025.

Hear from our 28 speakers who are leading roundtables, debates and collaborative discussions and network with our attendees as we tackle the current challenges facing the pharma industry.

The 2025 speaker lineup includes:

  • Ingrid Lux, Director, Quality Disposition Oncology and External Supply Small Molecule Europe, Takeda
  • Maik Talarczyk, Head, PMO ESO, Sandoz
  • Philip Coetzee, Director CMO Management, Daiichi Sankyo
  • Lucas Lucero Lopez, Associate Director, Vendor Management, AstraZeneca
  • Maria Palha, Associate Director, External Manufacturing Operations, UCB
  • Mohamed Fayez Monir, Head of Third Party Manufacturing, Boehringer Ingelheim

Key topics will include:

  • Embracing Sustainability: Exploring sustainable practices and reducing environmental impact.
  • Discussing Business Strategies: Particularly looking at pricing and contract negotiations.
  • Navigating Regulatory Changes: Understanding the implications of new regulations and developing compliance strategies.
  • Building Resilient Supply Chains: Mitigating risks and ensuring continuity of operations in a volatile environment.
  • Leveraging Digital Transformation: Harnessing technology to improve efficiency, quality, and innovation.

The full event agenda is available here for you to browse and use our code: PARTNER15 for 15% off your ticket.

Event venue: Mercure Hotel MOA Berlin , Stephanstraße 41 , 10559 Berlin, Germany

 

Previous Post

Scalability and therapeutic potential of induced pluripotent reprogramming and neural induction using small molecules

Next Post

Women Leaders in Biopharma: The Way Forward

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post

Women Leaders in Biopharma: The Way Forward

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In